In recent years, the rapid development of synthetic biology has brought new opportunities for the in-depth optimization of tumor bacterial therapy. Based on synthetic biology methods, scientists can use genetically engineered microorganisms or cells instead of traditional chemical small molecules or biological agents as the basis for the development of new disease treatments. Artificially designed microorganisms or cells carrying synthetic gene circuits can respond to disease